Modification of striatal arginine and citrulline metabolism by nitric oxide synthase inhibitors. 1994

K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

The effects of NG-substituted L-arginine (ARG) analogues on striatal ARG and citrulline (CIT) levels were investigated using in vivo microdialysis technique. A microdialysis probe was implanted into the striatum of anaesthesized Sprague-Dawley rats. Direct intrastriatal perfusion with 1 mM NG-nitro-L-arginine methyl ester (n = 8) increased striatal ARG release and decreased CIT release, suggesting suppressed NO synthase activity in the tissue. On the other hand, 1 mM NG-monomethyl-L-arginine (L-NMMA) (n = 6) evoked a persistent increase in both ARG and CIT. Considering that 4-320 microM L-ARG (n = 8) failed to increase CIT formation, CIT seems to be synthesized in the striatal tissue from L-NMMA by the enzyme that has been demonstrated in the kidney and aortic endothelium (NG,NG-dimethylarginine dimethyl-aminohydrolase).

UI MeSH Term Description Entries
D008297 Male Males
D002956 Citrulline
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D000594 Amino Acid Oxidoreductases A class of enzymes that catalyze oxidation-reduction reactions of amino acids. Acid Oxidoreductases, Amino,Oxidoreductases, Amino Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019001 Nitric Oxide Synthase An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE. NO Synthase,Nitric-Oxide Synthase,Nitric-Oxide Synthetase,Nitric Oxide Synthetase,Oxide Synthase, Nitric,Synthase, Nitric Oxide
D019323 omega-N-Methylarginine A competitive inhibitor of nitric oxide synthetase. D-NMMA,L-Monomethylarginine,L-NMMA,NG-Monomethyl-L-Arginine,L-NG-Monomethyl Arginine,N(G)-Methylarginine,N(G)-Monomethyl-D-Arginine,N(G)-Monomethylarginine,N(omega)-Monomethyl-L-Arginine,Arginine, L-NG-Monomethyl,L Monomethylarginine,L NG Monomethyl Arginine,NG Monomethyl L Arginine,omega N Methylarginine

Related Publications

K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
June 2009, Clinical science (London, England : 1979),
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
July 1992, Biochemical and biophysical research communications,
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
May 2000, The Journal of clinical investigation,
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
July 1997, Biochemical pharmacology,
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
June 1992, Biochemical and biophysical research communications,
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
June 1994, International journal of radiation oncology, biology, physics,
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
July 1999, Cellular and molecular life sciences : CMLS,
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
January 2005, Biochemical pharmacology,
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
December 1999, Biochemistry,
K Ohta, and K Shimazu, and S Komatsumoto, and N Araki, and M Shibata, and Y Fukuuchi
February 2004, European journal of pharmacology,
Copied contents to your clipboard!